2019: Phylogica Limited trading as PYC Therapeutics (ASX: PYC) ‘The Company’ or ‘PYC’ is pleased to announce the appointment of Dr. Fred K Chen to PYC’s Scientific Advisory Board (SAB). In addition to joining the SAB, Dr. Chen will also be the founding member of PYC’s Opthalmology Clinical Advisory Board – a specialist advisory board with the objective of guiding PYC’s ophthalmology pipeline through clinical evaluation.
Ann: Scientific Advisory Board Appointment, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 13.5¢ | $687.7K | 4.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87494 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 2187900 | 13 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |